White label ELPA - ClinicalTrials.eu

Study on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

Not recruiting

3 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Mitomycin
+1
Study on the Effects of TTI-0102 for Patients with MELAS Syndrome

Not recruiting

2 1
Investigated diseases:
- MELAS syndrome
Investigated drugs:
- Mercaptamine-Pantetheine Disulfide Acetate
Study on Istaroxime for Patients with Cardiogenic Shock Stage C

Not recruiting

2 1
Investigated diseases:
- Cardiogenic shock
Investigated drugs:
- Istaroxime
Safety Study of Tradipitant for Patients with Idiopathic or Diabetic Gastroparesis

Not recruiting

3 1 1
Investigated diseases:
- Diabetic gastroparesis
- Impaired gastric emptying
Investigated drugs:
- Tradipitant
Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Not recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Salbutamol
- Tozorakimab
+6
Study on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure

Not recruiting

4 1 1 1
Investigated diseases:
- Pancreatic carcinoma metastatic
Investigated drugs:
Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

Not recruiting

2 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Apg777
Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

Not recruiting

3 1 1 1
Investigated diseases:
- Metastatic malignant melanoma
Investigated drugs:
- Nivolumab
+6
Study on the Use of Casirivimab, Cilgavimab, Sotrovimab, and Nirmatrelvir for Patients with COVID-19 Infection

Not recruiting

3 1 1 1
Investigated diseases:
- COVID-19
Investigated drugs:
Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies